In a report released today, Lauren Lieberman from Barclays maintained a Buy rating on Keurig Dr Pepper (KDP – Research Report), with a price target of $38.00. The company’s shares closed last Friday at $34.40.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
According to TipRanks, Lieberman is a 4-star analyst with an average return of 2.2% and a 53.89% success rate. Lieberman covers the Consumer Defensive sector, focusing on stocks such as PepsiCo, Colgate-Palmolive, and Church & Dwight.
In addition to Barclays, Keurig Dr Pepper also received a Buy from HSBC’s Sorabh Daga in a report issued on April 25. However, on the same day, Truist Financial maintained a Hold rating on Keurig Dr Pepper (NASDAQ: KDP).
KDP market cap is currently $46.72B and has a P/E ratio of 31.16.
Based on the recent corporate insider activity of 39 insiders, corporate insider sentiment is neutral on the stock. Last month, Angela Stephens, the SVP & Controller of KDP sold 7,350.00 shares for a total of $251,149.50.
Read More on KDP:
- Keurig Dr Pepper Announces Board Leadership Changes
- China weighs U.S. tariff exemptions, Alphabet reports Q1 beat: Morning Buzz
- Keurig upgraded, Global Payments downgraded: Wall Street’s top analyst calls
- HSBC upgrades ‘steady’ Keurig Dr Pepper to Buy
- Keurig Dr Pepper upgraded to Buy from Hold at HSBC